BACKGROUND: There is a great need for the development of personalized prediction models (PPMs) that can predict the rate of disease progression for persons with Parkinson's disease (PD), based on their individual characteristics. In this study, we aimed to clarify the perspective of persons diagnosed with PD on the value of such hypothetical PPMs. METHODS: We organized four focus group discussions, each including five persons with PD who were diagnosed within the last 5 years. The sessions focused on what they think of receiving a personalized prediction; what outcomes are important to them; if and how the possibility of influencing the prognosis would change the way they think of personalized predictions; how they deal with the uncertainty...
BackgroundThe concerns of people with Parkinson's disease (PD) about their disease are often differe...
Parkinson disease (PD) is associated with a clinical course of variable duration, severity, and a co...
This thesis explores how people with Parkinson’s (PwP) and care partners of PwP manage the uncertain...
Abstract Background There is a great need for the development of personalized prediction models (PPM...
OBJECTIVE: To develop a prognostic model to predict disease outcomes in individual patients with Par...
BACKGROUND: Clinical trials of disease-modifying therapies in PD require valid and responsive primar...
Background: Our understanding of the etiology, pathophysiology, phenotypic diversity, and progressio...
Background: Our understanding of the etiology, pathophysiology, phenotypic diversity, and progressio...
Focusing clinical investigations on outcomes that are meaningful from an end-user perspective is cen...
© 2021 International Parkinson and Movement Disorder SocietyBackground: Expectations of benefit have...
Parkinson disease (PD) has a relatively long prodromal period that may permit early identification t...
Background: Recent research suggests that a significant number of those who receive advanced treatme...
Background: Parkinsonian syndromes are heterogeneous chronic neurodegenerative disorders associated ...
Parkinson disease (PD) is associated with a clinical course of variable duration, severity, and a co...
International audienceParkinson’s disease (PD) is a progressive neurodegenerative disease that affec...
BackgroundThe concerns of people with Parkinson's disease (PD) about their disease are often differe...
Parkinson disease (PD) is associated with a clinical course of variable duration, severity, and a co...
This thesis explores how people with Parkinson’s (PwP) and care partners of PwP manage the uncertain...
Abstract Background There is a great need for the development of personalized prediction models (PPM...
OBJECTIVE: To develop a prognostic model to predict disease outcomes in individual patients with Par...
BACKGROUND: Clinical trials of disease-modifying therapies in PD require valid and responsive primar...
Background: Our understanding of the etiology, pathophysiology, phenotypic diversity, and progressio...
Background: Our understanding of the etiology, pathophysiology, phenotypic diversity, and progressio...
Focusing clinical investigations on outcomes that are meaningful from an end-user perspective is cen...
© 2021 International Parkinson and Movement Disorder SocietyBackground: Expectations of benefit have...
Parkinson disease (PD) has a relatively long prodromal period that may permit early identification t...
Background: Recent research suggests that a significant number of those who receive advanced treatme...
Background: Parkinsonian syndromes are heterogeneous chronic neurodegenerative disorders associated ...
Parkinson disease (PD) is associated with a clinical course of variable duration, severity, and a co...
International audienceParkinson’s disease (PD) is a progressive neurodegenerative disease that affec...
BackgroundThe concerns of people with Parkinson's disease (PD) about their disease are often differe...
Parkinson disease (PD) is associated with a clinical course of variable duration, severity, and a co...
This thesis explores how people with Parkinson’s (PwP) and care partners of PwP manage the uncertain...